Back to Journals » Journal of Hepatocellular Carcinoma » Volume 10

Original Research

Efficacy and Safety of Tyrosine Kinase Inhibitors Alone or Combination with Programmed Death-1 Inhibitors in Treating of Hepatitis C-Related Hepatocellular Carcinoma

       
Total article views   HTML views PDF downloads Totals
2,932 Dovepress* 2,770+ 63 2,833
PubMed Central* 162 56 218
Totals 2,932 119 3,051
*Since 2 March 2023

View citations on PubMed Central and Google Scholar